Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres








Gamme d'année
1.
Biol. Res ; 41(2): 129-136, 2008. ilus, graf
Article de Anglais | LILACS | ID: lil-495746

RÉSUMÉ

We have previously characterized a number of small molecule organic compounds that prevent the aggregation of the β-amyloid peptide and its neurotoxicity in hippocampal neuronal cultures. We have now evaluated the effects of such compounds on amyloid precursor protein (APP) accumulation in the CTb immortalized cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down's syndrome. Compared to a non-trisomic cortical cell line (CNh), CTb cells overexpress APP and exhibit slightly elevated resting intracellular Ca2+ levéis ([Ca2+]¡). Here, we show that the compounds 2,4-dinitrophenol, 3-nitrophenol and 4-anisidine decreased intracellular accumulation of APP in CTb cells. Those compounds were non-toxic to the cells, and slightly increased the basal [Ca2+]¡. Results indícate that the compounds tested can be leads for the development of drugs to decrease intracellular vesicular accumulation of APP in trisomic cells.


Sujet(s)
Animaux , Souris , Maladie d'Alzheimer/métabolisme , Précurseur de la protéine bêta-amyloïde/antagonistes et inhibiteurs , Dérivés de l'aniline/pharmacologie , Syndrome de Down/métabolisme , Nitrophénols/pharmacologie , /pharmacologie , Précurseur de la protéine bêta-amyloïde/métabolisme , Lignée cellulaire , Cortex cérébral/cytologie , Cortex cérébral/effets des médicaments et des substances chimiques , Cortex cérébral/métabolisme , Modèles animaux de maladie humaine
2.
Braz. j. med. biol. res ; 34(5): 597-601, May 2001. ilus
Article de Anglais | LILACS | ID: lil-285873

RÉSUMÉ

Extensive neuronal cell loss is observed in Alzheimer's disease. Laminin immunoreactivity colocalizes with senile plaques, the characteristic extracellular histopathological lesions of Alzheimer brain, which consist of the amyloid ß (Aß) peptide polymerized into amyloid fibrils. These lesions have neurotoxic effects and have been proposed to be a main cause of neurodegeneration. In order to understand the pathological significance of the interaction between laminin and amyloid, we investigated the effect of laminin on amyloid structure and toxicity. We found that laminin interacts with the Aß1-40 peptide, blocking fibril formation and even inducing depolymerization of preformed fibrils. Protofilaments known to be intermediate species of Aß fibril formation were also detected as intermediate species of laminin-induced Aß fibril depolymerization. Moreover, laminin-amyloid interactions inhibited the toxic effects on rat primary hippocampal neurons. As a whole, our results indicate a putative anti-amyloidogenic role of laminin which may be of biological and therapeutic interest for controlling amyloidosis, such as those observed in cerebral angiopathy and Alzheimer's disease


Sujet(s)
Humains , Animaux , Maladie d'Alzheimer/anatomopathologie , Précurseur de la protéine bêta-amyloïde/métabolisme , Matrice extracellulaire/métabolisme , Laminine/métabolisme , Maladie d'Alzheimer/métabolisme , Précurseur de la protéine bêta-amyloïde/antagonistes et inhibiteurs , Précurseur de la protéine bêta-amyloïde/toxicité , Amyloïdose/métabolisme , Laminine/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE